The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Durvalumab
Australian Public Assessment Report
Device/Product Name
Imfinzi
Active ingredients
Durvalumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-04661-1-4
Submission Type
Extension of indications
Decision
Approved